[1]
M. Cruz Barrios and J. Furones Mourelle, “Benefit-risk use of transfer factor (Hebertrans®) in usual medical practice”, HS, vol. 18, no. 2, pp. 235–242, Apr. 2019, doi: 10.19136/hs.a18n2.2918.